Eric Marsh
Boston Children's Hospital
7 Papers
50 Citations
Eric Marsh is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Injury prevention & Poison control. The author has an hindex of 5, co-authored 7 publications.
Chat about Author
Papers
•Journal Article
Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a multi-center, randomized, double-blind, placebo controlled trial (GWPCARE4) (S21.001)
Jacqueline A. French,Elizabeth A. Thiele,Maria Mazurkiewicz-Bełdzińska,Selim R. Benbadis,Eric Marsh,Charuta Joshi,Claire Roberts,Adam Taylor,Ken Sommerville +8 more
TL;DR: Results from this trial suggest that CBD add-on therapy for the treatment of drop seizures associated with LGS may be efficacious and generally well-tolerated.
24
Pediatric airbag injuries: the Ohio experience.
Enrique R. Grisoni,Srikumar B. Pillai,Teresa A Volsko,Khaled H. Mutabagani,Victor F. Garcia,Kathy Haley,Lynn Schweer,Eric Marsh,Donald R. Cooney +8 more
TL;DR: The data showed that airbags, with or without proper safety restraints, can lead to mortality or serious morbidity in children.
21
Preventing bicycle-related head trauma in children * ** * ** * **
TL;DR: By incorporating the behavioral theory of self-efficacy in the structure of the Health Belief Model, trauma care providers and injury prevention specialists will be better able to design successful injury prevention programs that address key variables in health-related decision making.
9
•Journal Article
Cannabidiol (CBD) reduces convulsive seizure frequency in Dravet syndrome: results of a multi-center, randomized, controlled trial (GWPCARE1) (CT.001)
J. Helen Cross,Orrin Devinsky,Eric Marsh,Ian Miller,Rima Nabbout,Ingrid E. Scheffer,Elizabeth A. Thiele,Linda Laux,Stephen Wright +8 more
TL;DR: In this study, CBD resulted in greater reduction in seizure frequency than placebo; adverse events were more frequent with CBD, but it was generally well-tolerated.
6
A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials.
Melissa Raspa,Carla Bann,Angela Gwaltney,Tim A. Benke,Cary Fu,Daniel G. Glaze,Richard H. Haas,Peter Heydemann,Mary Jones,Walter E. Kaufmann,David N. Lieberman,Eric Marsh,Sarika U. Peters,Robin C. C. Ryther,Shannon M. Standridge,Steven A. Skinner,Alan K. Percy,Jeffrey L. Neul +17 more
TL;DR: In this paper, the authors examined the factor structure, internal consistency, and validity of the clinician-reported motor behavior assessment scale (MBA) and found that all items had acceptable discrimination, including motor dysfunction, functional skills, social skills, aberrant behavior, and respiratory behaviors.